Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
Saved in:
| Title: | Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses. |
|---|---|
| Authors: | Brodowicz, T1, Lang, I2, Kahan, Z3, Greil, R4, Beslija, S5, Stemmer, S M6, Kaufman, B7, Petruzelka, L8, Eniu, A9, Anghel, R10, Koynov, K11, Vrbanec, D12, Pienkowski, T13, Melichar, B14, Spanik, S15, Ahlers, S16, Messinger, D16, Inbar, M J17, Zielinski, C1 |
| Source: | British Journal of Cancer. 11/25/2014, Vol. 111 Issue 11, p2051-2057. 7p. 4 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
